Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Mauro Giuseppe Mastropasqua"'
Autor:
Antonio d’Amati, Marta Mariano, Francesca Addante, Giovanna Giliberti, Giovanni Tomasicchio, Mauro Giuseppe Mastropasqua
Publikováno v:
Reports, Vol 5, Iss 4, p 38 (2022)
The presence of stromal osteoclast-like giant cells is a distinctive feature of some rare breast tumors, accounting for less than 1% of all breast cancer cases. Although the presence of stromal osteoclast-like giant cells may be encountered in differ
Externí odkaz:
https://doaj.org/article/abb2757699c745d6ac54d52508926f68
Autor:
Mariia Ivanova, Konstantinos Venetis, Elena Guerini-Rocco, Luca Bottiglieri, Mauro Giuseppe Mastropasqua, Ornella Garrone, Nicola Fusco, Michele Ghidini
Publikováno v:
Life, Vol 12, Iss 9, p 1403 (2022)
HER2 is an emerging biomarker in colorectal cancer (CRC). This oncogene plays an essential role in regulating cell proliferation, differentiation, migration, and, more in general, tumorigenesis and tumor progression. The most frequent types of HER2 a
Externí odkaz:
https://doaj.org/article/b9afc787e5b64098ba3c616df0adb36c
Autor:
Luca Nicosia, Antuono Latronico, Francesca Addante, Rossella De Santis, Anna Carla Bozzini, Marta Montesano, Samuele Frassoni, Vincenzo Bagnardi, Giovanni Mazzarol, Oriana Pala, Matteo Lazzeroni, Germana Lissidini, Mauro Giuseppe Mastropasqua, Enrico Cassano
Publikováno v:
Diagnostics, Vol 11, Iss 6, p 1120 (2021)
(1) Background: to evaluate which factors can reduce the upgrade rate of atypical ductal hyperplasia (ADH) to in situ or invasive carcinoma in patients who underwent vacuum-assisted breast biopsy (VABB) and subsequent surgical excision. (2) Methods:
Externí odkaz:
https://doaj.org/article/9385adae1e764083993036e583718380
Autor:
Elena Guerini-Rocco, Gerardo Botti, Maria Pia Foschini, Caterina Marchiò, Mauro Giuseppe Mastropasqua, Giuseppe Perrone, Elena Roz, Alfredo Santinelli, Isabella Sassi, Viviana Galimberti, Luca Gianni, Giuseppe Viale
Publikováno v:
Tumori. 108(3)
Pathologic evaluation of early breast cancer after neoadjuvant therapy is essential to provide prognostic information based on tumor response to treatment (pathologic complete response [pCR] or non-pCR) and to inform therapy decisions after surgery.
Autor:
Giustina Angellotti, Giovanni Tomasicchio, Alda Elena Montanaro, Michele Telgrafo, Mauro Giuseppe Mastropasqua, Clelia Punzo
Publikováno v:
International Journal of Surgery Case Reports. 97:107421
Breast Cancer with osteoclast-like stromal giant cells (OLGCs) is a rare pattern of invasive non-special type ductal carcinoma. The OLGCs are specific type of macrophage and are likely distinct from true osteoclasts. The aim of this case series was t
Autor:
Anna Rotili, Marianna Fanizza, Giuseppe Renne, Francesco Ballati, Matteo Lazzeroni, Giuseppe Di Giulio, Luca Nicosia, and Mauro Giuseppe Mastropasqua, Antuono Latronico, Anna Bozzini, Francesca Abbate, Francesca Addante, Marco Lucioni, Enrico Cassano
(1) Background: Considering highly selected patients with ductal carcinoma in situ (DCIS), active surveillance is a valid alternative to surgery. Our study is aimed at showing the reliability of post-biopsy complete lesion removal, documented by mamm
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5582790adb64b3fa9795958a6071d2da
https://doi.org/10.20944/preprints202012.0806.v1
https://doi.org/10.20944/preprints202012.0806.v1
Autor:
Mauro Giuseppe MASTROPASQUA
Publikováno v:
Archives of surgery and clinical case reports.
Publikováno v:
Encyclopedia of Pathology ISBN: 9783319288451
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::06951d915fb5e8fe880a599d6ebfa809
https://doi.org/10.1007/978-3-319-28845-1_4698-1
https://doi.org/10.1007/978-3-319-28845-1_4698-1
Autor:
Elisabetta Munzone, Zsolt Horváth, Lorenza Rimassa, Eugenio Maiorano, Eva Sedlackova, Eva Segelov, Tamas Hickish, Jose Luis González Larriba, Jorge Villanova Biazus, Ignazio CARRECA, Mauro Giuseppe MASTROPASQUA, Wojciech Olszewski, David Wyld, Gaetan MacGrogan, Andrew Wardley, Pavel Vitek, Joaquín Fra Rodríguez, Timothy Perren, Tadeusz Pienkowski, Lubos Petruzelka, Laurence Gladieff
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 26(34)
PurposeTo evaluate the prognostic and predictive value of Ki-67 labeling index (LI) in a trial comparing letrozole (Let) with tamoxifen (Tam) as adjuvant therapy in postmenopausal women with early breast cancer.Patients and MethodsBreast Internationa